← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Chief Business Officer Pamela Esposito sold $135K of Replimune Group, Inc.

Sold$135,250
$27.05Price
5,000Shares
−4%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Mon, Aug 31. Filed Tue, Sep 1, 1:13 PM ET, during the session. Not investment advice.